ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Vaccine Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-476
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Human Vaccine Market Research Report 2024

Code: QYRE-Auto-476
Report
February 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
Sanofi
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
Zhongke Biopharm
Zhuoyi Biological

Human Vaccine Market Size

The global Human Vaccine market was valued at US$ 31950 million in 2023 and is anticipated to reach US$ 44100 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.

Human Vaccine Market

Human Vaccine Market

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine.

Report Scope

The Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Vaccine Market Report

Report Metric Details
Report Name Human Vaccine Market
Accounted market size in 2023 US$ 31950 million
Forecasted market size in 2030 US$ 44100 million
CAGR 4.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CNBG, Changsheng Life, Zhifei, ChengDa Bio, Kangtai, SINOVAC BIOTECH, Hissen, Walvax Biotechnology, GSK, SANOFI, Rong An, NuoCheng Bio, Hualan Bio, Tiantan biological, Changchun Baike, Adimmune, Zhongyianke Biotech, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Indian Immunologicals, KANGH, Henan Grand Biopharma, ZhongKe Biopharm, Zhuoyi Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Vaccine Market growing?

Ans: The Human Vaccine Market witnessing a CAGR of 4.6% during the forecast period 2024-2030.

What is the Human Vaccine Market size in 2030?

Ans: The Human Vaccine Market size in 2030 will be US$ 44100 million.

What is the market share of major companies in Human Vaccine Market?

Ans: Global top three manufacturers hold a share about 65%.

What is the Human Vaccine Market share by type?

Ans: In terms of product, Hepatitis B is the largest segment, with a share nearly 15%.

Who are the main players in the Human Vaccine Market report?

Ans: The main players in the Human Vaccine Market are CNBG, Changsheng Life, Zhifei, ChengDa Bio, Kangtai, SINOVAC BIOTECH, Hissen, Walvax Biotechnology, GSK, SANOFI, Rong An, NuoCheng Bio, Hualan Bio, Tiantan biological, Changchun Baike, Adimmune, Zhongyianke Biotech, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Indian Immunologicals, KANGH, Henan Grand Biopharma, ZhongKe Biopharm, Zhuoyi Biological

What are the Application segmentation covered in the Human Vaccine Market report?

Ans: The Applications covered in the Human Vaccine Market report are Adults, Children

What are the Type segmentation covered in the Human Vaccine Market report?

Ans: The Types covered in the Human Vaccine Market report are Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine

1 Human Vaccine Market Overview
1.1 Product Overview and Scope of Human Vaccine
1.2 Human Vaccine Segment by Type
1.2.1 Global Human Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Human Vaccine Segment by Application
1.3.1 Global Human Vaccine Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Human Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Vaccine Revenue 2019-2030
1.4.2 Global Human Vaccine Sales 2019-2030
1.4.3 Global Human Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Vaccine Market Competition by Manufacturers
2.1 Global Human Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Human Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Vaccine, Product Type & Application
2.7 Human Vaccine Market Competitive Situation and Trends
2.7.1 Human Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Vaccine Players Market Share by Revenue
2.7.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Vaccine Retrospective Market Scenario by Region
3.1 Global Human Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Vaccine Global Human Vaccine Sales by Region: 2019-2030
3.2.1 Global Human Vaccine Sales by Region: 2019-2024
3.2.2 Global Human Vaccine Sales by Region: 2025-2030
3.3 Global Human Vaccine Global Human Vaccine Revenue by Region: 2019-2030
3.3.1 Global Human Vaccine Revenue by Region: 2019-2024
3.3.2 Global Human Vaccine Revenue by Region: 2025-2030
3.4 North America Human Vaccine Market Facts & Figures by Country
3.4.1 North America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Vaccine Sales by Country (2019-2030)
3.4.3 North America Human Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Vaccine Sales by Country (2019-2030)
3.5.3 Europe Human Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Human Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Vaccine Sales by Type (2019-2030)
4.1.1 Global Human Vaccine Sales by Type (2019-2024)
4.1.2 Global Human Vaccine Sales by Type (2025-2030)
4.1.3 Global Human Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Human Vaccine Revenue by Type (2019-2030)
4.2.1 Global Human Vaccine Revenue by Type (2019-2024)
4.2.2 Global Human Vaccine Revenue by Type (2025-2030)
4.2.3 Global Human Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Human Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Vaccine Sales by Application (2019-2030)
5.1.1 Global Human Vaccine Sales by Application (2019-2024)
5.1.2 Global Human Vaccine Sales by Application (2025-2030)
5.1.3 Global Human Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Human Vaccine Revenue by Application (2019-2030)
5.2.1 Global Human Vaccine Revenue by Application (2019-2024)
5.2.2 Global Human Vaccine Revenue by Application (2025-2030)
5.2.3 Global Human Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Human Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CNBG
6.1.1 CNBG Corporation Information
6.1.2 CNBG Description and Business Overview
6.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CNBG Human Vaccine Product Portfolio
6.1.5 CNBG Recent Developments/Updates
6.2 Changsheng Life
6.2.1 Changsheng Life Corporation Information
6.2.2 Changsheng Life Description and Business Overview
6.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Changsheng Life Human Vaccine Product Portfolio
6.2.5 Changsheng Life Recent Developments/Updates
6.3 Zhifei
6.3.1 Zhifei Corporation Information
6.3.2 Zhifei Description and Business Overview
6.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zhifei Human Vaccine Product Portfolio
6.3.5 Zhifei Recent Developments/Updates
6.4 ChengDa Bio
6.4.1 ChengDa Bio Corporation Information
6.4.2 ChengDa Bio Description and Business Overview
6.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ChengDa Bio Human Vaccine Product Portfolio
6.4.5 ChengDa Bio Recent Developments/Updates
6.5 Kangtai
6.5.1 Kangtai Corporation Information
6.5.2 Kangtai Description and Business Overview
6.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kangtai Human Vaccine Product Portfolio
6.5.5 Kangtai Recent Developments/Updates
6.6 SINOVAC BIOTECH
6.6.1 SINOVAC BIOTECH Corporation Information
6.6.2 SINOVAC BIOTECH Description and Business Overview
6.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
6.6.5 SINOVAC BIOTECH Recent Developments/Updates
6.7 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hissen Human Vaccine Product Portfolio
6.7.5 Hissen Recent Developments/Updates
6.8 Walvax Biotechnology
6.8.1 Walvax Biotechnology Corporation Information
6.8.2 Walvax Biotechnology Description and Business Overview
6.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
6.8.5 Walvax Biotechnology Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK Human Vaccine Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 SANOFI
6.10.1 SANOFI Corporation Information
6.10.2 SANOFI Description and Business Overview
6.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SANOFI Human Vaccine Product Portfolio
6.10.5 SANOFI Recent Developments/Updates
6.11 Rong An
6.11.1 Rong An Corporation Information
6.11.2 Rong An Human Vaccine Description and Business Overview
6.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Rong An Human Vaccine Product Portfolio
6.11.5 Rong An Recent Developments/Updates
6.12 NuoCheng Bio
6.12.1 NuoCheng Bio Corporation Information
6.12.2 NuoCheng Bio Human Vaccine Description and Business Overview
6.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NuoCheng Bio Human Vaccine Product Portfolio
6.12.5 NuoCheng Bio Recent Developments/Updates
6.13 Hualan Bio
6.13.1 Hualan Bio Corporation Information
6.13.2 Hualan Bio Human Vaccine Description and Business Overview
6.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hualan Bio Human Vaccine Product Portfolio
6.13.5 Hualan Bio Recent Developments/Updates
6.14 Tiantan biological
6.14.1 Tiantan biological Corporation Information
6.14.2 Tiantan biological Human Vaccine Description and Business Overview
6.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Tiantan biological Human Vaccine Product Portfolio
6.14.5 Tiantan biological Recent Developments/Updates
6.15 Changchun Baike
6.15.1 Changchun Baike Corporation Information
6.15.2 Changchun Baike Human Vaccine Description and Business Overview
6.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changchun Baike Human Vaccine Product Portfolio
6.15.5 Changchun Baike Recent Developments/Updates
6.16 Adimmune
6.16.1 Adimmune Corporation Information
6.16.2 Adimmune Human Vaccine Description and Business Overview
6.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Adimmune Human Vaccine Product Portfolio
6.16.5 Adimmune Recent Developments/Updates
6.17 Zhongyianke Biotech
6.17.1 Zhongyianke Biotech Corporation Information
6.17.2 Zhongyianke Biotech Human Vaccine Description and Business Overview
6.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
6.17.5 Zhongyianke Biotech Recent Developments/Updates
6.18 Bharat Biotech
6.18.1 Bharat Biotech Corporation Information
6.18.2 Bharat Biotech Human Vaccine Description and Business Overview
6.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bharat Biotech Human Vaccine Product Portfolio
6.18.5 Bharat Biotech Recent Developments/Updates
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Corporation Information
6.19.2 Bavarian Nordic Human Vaccine Description and Business Overview
6.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bavarian Nordic Human Vaccine Product Portfolio
6.19.5 Bavarian Nordic Recent Developments/Updates
6.20 Sanofi-Pasteur
6.20.1 Sanofi-Pasteur Corporation Information
6.20.2 Sanofi-Pasteur Human Vaccine Description and Business Overview
6.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
6.20.5 Sanofi-Pasteur Recent Developments/Updates
6.21 Indian Immunologicals
6.21.1 Indian Immunologicals Corporation Information
6.21.2 Indian Immunologicals Human Vaccine Description and Business Overview
6.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Indian Immunologicals Human Vaccine Product Portfolio
6.21.5 Indian Immunologicals Recent Developments/Updates
6.22 KANGH
6.22.1 KANGH Corporation Information
6.22.2 KANGH Human Vaccine Description and Business Overview
6.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 KANGH Human Vaccine Product Portfolio
6.22.5 KANGH Recent Developments/Updates
6.23 Henan Grand Biopharma
6.23.1 Henan Grand Biopharma Corporation Information
6.23.2 Henan Grand Biopharma Human Vaccine Description and Business Overview
6.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
6.23.5 Henan Grand Biopharma Recent Developments/Updates
6.24 ZhongKe Biopharm
6.24.1 ZhongKe Biopharm Corporation Information
6.24.2 ZhongKe Biopharm Human Vaccine Description and Business Overview
6.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
6.24.5 ZhongKe Biopharm Recent Developments/Updates
6.25 Zhuoyi Biological
6.25.1 Zhuoyi Biological Corporation Information
6.25.2 Zhuoyi Biological Human Vaccine Description and Business Overview
6.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
6.25.5 Zhuoyi Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Vaccine Industry Chain Analysis
7.2 Human Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Vaccine Production Mode & Process
7.4 Human Vaccine Sales and Marketing
7.4.1 Human Vaccine Sales Channels
7.4.2 Human Vaccine Distributors
7.5 Human Vaccine Customers
8 Human Vaccine Market Dynamics
8.1 Human Vaccine Industry Trends
8.2 Human Vaccine Market Drivers
8.3 Human Vaccine Market Challenges
8.4 Human Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
Sanofi
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
Zhongke Biopharm
Zhuoyi Biological
List of Tables
    Table 1. Global Human Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Human Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Human Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Human Vaccine Sales (M Doses) of Key Manufacturers (2019-2024)
    Table 5. Global Human Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Human Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Human Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Human Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Human Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Human Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Human Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Human Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Human Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Human Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Human Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 18. Global Human Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Human Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 20. Global Human Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Human Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Human Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Human Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Human Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Human Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 27. North America Human Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 28. North America Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Human Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 32. Europe Human Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 33. Europe Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Human Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Human Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 37. Asia Pacific Human Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 38. Asia Pacific Human Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Human Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Human Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 42. Latin America Human Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 43. Latin America Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Human Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Human Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 47. Middle East & Africa Human Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 48. Middle East & Africa Human Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Human Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Human Vaccine Sales (M Doses) by Type (2019-2024)
    Table 51. Global Human Vaccine Sales (M Doses) by Type (2025-2030)
    Table 52. Global Human Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Human Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Human Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Human Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Human Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Human Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Human Vaccine Price (USD/Dose) by Type (2019-2024)
    Table 59. Global Human Vaccine Price (USD/Dose) by Type (2025-2030)
    Table 60. Global Human Vaccine Sales (M Doses) by Application (2019-2024)
    Table 61. Global Human Vaccine Sales (M Doses) by Application (2025-2030)
    Table 62. Global Human Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Human Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Human Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Human Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Human Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Human Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Human Vaccine Price (USD/Dose) by Application (2019-2024)
    Table 69. Global Human Vaccine Price (USD/Dose) by Application (2025-2030)
    Table 70. CNBG Corporation Information
    Table 71. CNBG Description and Business Overview
    Table 72. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 73. CNBG Human Vaccine Product
    Table 74. CNBG Recent Developments/Updates
    Table 75. Changsheng Life Corporation Information
    Table 76. Changsheng Life Description and Business Overview
    Table 77. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 78. Changsheng Life Human Vaccine Product
    Table 79. Changsheng Life Recent Developments/Updates
    Table 80. Zhifei Corporation Information
    Table 81. Zhifei Description and Business Overview
    Table 82. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 83. Zhifei Human Vaccine Product
    Table 84. Zhifei Recent Developments/Updates
    Table 85. ChengDa Bio Corporation Information
    Table 86. ChengDa Bio Description and Business Overview
    Table 87. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 88. ChengDa Bio Human Vaccine Product
    Table 89. ChengDa Bio Recent Developments/Updates
    Table 90. Kangtai Corporation Information
    Table 91. Kangtai Description and Business Overview
    Table 92. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 93. Kangtai Human Vaccine Product
    Table 94. Kangtai Recent Developments/Updates
    Table 95. SINOVAC BIOTECH Corporation Information
    Table 96. SINOVAC BIOTECH Description and Business Overview
    Table 97. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 98. SINOVAC BIOTECH Human Vaccine Product
    Table 99. SINOVAC BIOTECH Recent Developments/Updates
    Table 100. Hissen Corporation Information
    Table 101. Hissen Description and Business Overview
    Table 102. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 103. Hissen Human Vaccine Product
    Table 104. Hissen Recent Developments/Updates
    Table 105. Walvax Biotechnology Corporation Information
    Table 106. Walvax Biotechnology Description and Business Overview
    Table 107. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 108. Walvax Biotechnology Human Vaccine Product
    Table 109. Walvax Biotechnology Recent Developments/Updates
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Business Overview
    Table 112. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 113. GSK Human Vaccine Product
    Table 114. GSK Recent Developments/Updates
    Table 115. SANOFI Corporation Information
    Table 116. SANOFI Description and Business Overview
    Table 117. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 118. SANOFI Human Vaccine Product
    Table 119. SANOFI Recent Developments/Updates
    Table 120. Rong An Corporation Information
    Table 121. Rong An Description and Business Overview
    Table 122. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 123. Rong An Human Vaccine Product
    Table 124. Rong An Recent Developments/Updates
    Table 125. NuoCheng Bio Corporation Information
    Table 126. NuoCheng Bio Description and Business Overview
    Table 127. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 128. NuoCheng Bio Human Vaccine Product
    Table 129. NuoCheng Bio Recent Developments/Updates
    Table 130. Hualan Bio Corporation Information
    Table 131. Hualan Bio Description and Business Overview
    Table 132. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 133. Hualan Bio Human Vaccine Product
    Table 134. Hualan Bio Recent Developments/Updates
    Table 135. Tiantan biological Corporation Information
    Table 136. Tiantan biological Description and Business Overview
    Table 137. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 138. Tiantan biological Human Vaccine Product
    Table 139. Tiantan biological Recent Developments/Updates
    Table 140. Changchun Baike Corporation Information
    Table 141. Changchun Baike Description and Business Overview
    Table 142. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 143. Changchun Baike Human Vaccine Product
    Table 144. Changchun Baike Recent Developments/Updates
    Table 145. Adimmune Corporation Information
    Table 146. Adimmune Description and Business Overview
    Table 147. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 148. Adimmune Human Vaccine Product
    Table 149. Adimmune Recent Developments/Updates
    Table 150. Zhongyianke Biotech Corporation Information
    Table 151. Zhongyianke Biotech Description and Business Overview
    Table 152. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 153. Zhongyianke Biotech Human Vaccine Product
    Table 154. Zhongyianke Biotech Recent Developments/Updates
    Table 155. Bharat Biotech Corporation Information
    Table 156. Bharat Biotech Description and Business Overview
    Table 157. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 158. Bharat Biotech Human Vaccine Product
    Table 159. Bharat Biotech Recent Developments/Updates
    Table 160. Bavarian Nordic Corporation Information
    Table 161. Bavarian Nordic Description and Business Overview
    Table 162. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 163. Bavarian Nordic Human Vaccine Product
    Table 164. Bavarian Nordic Recent Developments/Updates
    Table 165. Sanofi-Pasteur Corporation Information
    Table 166. Sanofi-Pasteur Description and Business Overview
    Table 167. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 168. Sanofi-Pasteur Human Vaccine Product
    Table 169. Sanofi-Pasteur Recent Developments/Updates
    Table 170. Indian Immunologicals Corporation Information
    Table 171. Indian Immunologicals Description and Business Overview
    Table 172. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 173. Indian Immunologicals Human Vaccine Product
    Table 174. Indian Immunologicals Recent Developments/Updates
    Table 175. KANGH Corporation Information
    Table 176. KANGH Description and Business Overview
    Table 177. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 178. KANGH Human Vaccine Product
    Table 179. KANGH Recent Developments/Updates
    Table 180. Henan Grand Biopharma Corporation Information
    Table 181. Henan Grand Biopharma Description and Business Overview
    Table 182. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 183. Henan Grand Biopharma Human Vaccine Product
    Table 184. Henan Grand Biopharma Recent Developments/Updates
    Table 185. ZhongKe Biopharm Corporation Information
    Table 186. ZhongKe Biopharm Description and Business Overview
    Table 187. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 188. ZhongKe Biopharm Human Vaccine Product
    Table 189. ZhongKe Biopharm Recent Developments/Updates
    Table 190. Zhuoyi Biological Corporation Information
    Table 191. Zhuoyi Biological Description and Business Overview
    Table 192. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 193. Zhuoyi Biological Human Vaccine Product
    Table 194. Zhuoyi Biological Recent Developments/Updates
    Table 195. Key Raw Materials Lists
    Table 196. Raw Materials Key Suppliers Lists
    Table 197. Human Vaccine Distributors List
    Table 198. Human Vaccine Customers List
    Table 199. Human Vaccine Market Trends
    Table 200. Human Vaccine Market Drivers
    Table 201. Human Vaccine Market Challenges
    Table 202. Human Vaccine Market Restraints
    Table 203. Research Programs/Design for This Report
    Table 204. Key Data Information from Secondary Sources
    Table 205. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Human Vaccine
    Figure 2. Global Human Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Human Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Varicella Product Picture
    Figure 5. Influenza Product Picture
    Figure 6. Polio Product Picture
    Figure 7. Hepatitis A Product Picture
    Figure 8. Rabies Product Picture
    Figure 9. BCG Product Picture
    Figure 10. Hepatitis B Product Picture
    Figure 11. Pertussis, Diphtheria, Tetanus Product Picture
    Figure 12. Pneumococcal Product Picture
    Figure 13. Rota vaccine Product Picture
    Figure 14. Global Human Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 15. Global Human Vaccine Market Share by Application in 2023 & 2030
    Figure 16. Adults
    Figure 17. Children
    Figure 18. Global Human Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Human Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 20. Global Human Vaccine Sales (2019-2030) & (M Doses)
    Figure 21. Global Human Vaccine Average Price (USD/Dose) & (2019-2030)
    Figure 22. Human Vaccine Report Years Considered
    Figure 23. Human Vaccine Sales Share by Manufacturers in 2023
    Figure 24. Global Human Vaccine Revenue Share by Manufacturers in 2023
    Figure 25. The Global 5 and 10 Largest Human Vaccine Players: Market Share by Revenue in 2023
    Figure 26. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 27. Global Human Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 28. North America Human Vaccine Sales Market Share by Country (2019-2030)
    Figure 29. North America Human Vaccine Revenue Market Share by Country (2019-2030)
    Figure 30. U.S. Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Canada Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Europe Human Vaccine Sales Market Share by Country (2019-2030)
    Figure 33. Europe Human Vaccine Revenue Market Share by Country (2019-2030)
    Figure 34. Germany Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. France Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. U.K. Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Italy Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Russia Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Asia Pacific Human Vaccine Sales Market Share by Region (2019-2030)
    Figure 40. Asia Pacific Human Vaccine Revenue Market Share by Region (2019-2030)
    Figure 41. China Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Japan Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. South Korea Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. India Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Australia Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Taiwan Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Indonesia Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Thailand Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Malaysia Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Philippines Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Latin America Human Vaccine Sales Market Share by Country (2019-2030)
    Figure 52. Latin America Human Vaccine Revenue Market Share by Country (2019-2030)
    Figure 53. Mexico Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Brazil Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Argentina Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Middle East & Africa Human Vaccine Sales Market Share by Country (2019-2030)
    Figure 57. Middle East & Africa Human Vaccine Revenue Market Share by Country (2019-2030)
    Figure 58. Turkey Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 60. U.A.E Human Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 61. Global Sales Market Share of Human Vaccine by Type (2019-2030)
    Figure 62. Global Revenue Market Share of Human Vaccine by Type (2019-2030)
    Figure 63. Global Human Vaccine Price (USD/Dose) by Type (2019-2030)
    Figure 64. Global Sales Market Share of Human Vaccine by Application (2019-2030)
    Figure 65. Global Revenue Market Share of Human Vaccine by Application (2019-2030)
    Figure 66. Global Human Vaccine Price (USD/Dose) by Application (2019-2030)
    Figure 67. Human Vaccine Value Chain
    Figure 68. Human Vaccine Production Process
    Figure 69. Channels of Distribution (Direct Vs Distribution)
    Figure 70. Distributors Profiles
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions